LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of “Buy” by Analysts
Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) have received a consensus recommendation of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 […]
Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) have received a consensus recommendation of “Buy” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 […]
